Dr. David T. Rock, MD

Dr. Rock practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Rock's NPI, 1356391791, was assigned on May 10, 2006. Dr. Rock graduated from VCU School of Medicine in 1991. Dr. Rock holds Florida license ME110898.

Dr. Rock's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Rock's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Rock is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Rock to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rock practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Rock's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Rock is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Rock's licenses on file in 3 states: Florida, Georgia and North Carolina.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Rock treats.

CMS data shows 417 Medicare services from Dr. Rock across 10 procedure codes in 2024, for 253 Medicare patients. Medicare paid $43,156 for them.

CMS counts 253 Medicare patients who saw Dr. Rock in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rock's median patient age at 69, with 96% women.

In 2024, Dr. Rock wrote 152 Medicare Part D claims for 100 patients. 99% of them were for generic drugs. CMS names the drug for 100 of them, across 3 drugs with 11 or more claims each, at $806 in total drug cost. In 2023, CMS named 225 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rock for performance year 2024, reported individually. Dr. Rock accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of mastectomy by Dr. Rock, more than 78% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Rock, published from 2020 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Decision Making. Dr. Rock has published most often in Ann Surg Oncol. Dr. Rock's most frequent co-authors are James V. Pellicane, FACS, MD, Pat W. Whitworth, MD and Anushka H. Patel, MD.

Dmand AI links Dr. Rock to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ. Agendia sponsors the most, 2.

CMS Open Payments shows 88 general payments to Dr. Rock from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Genentech, Inc. paid the most, $61,220.

Dmand AI lists 1 award for Dr. Rock.

Dr. Rock graduated from VCU School of Medicine in 1991. Dr. Rock is a member of ACS.

Dr. Rock is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.